CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
lifesciencesreview
US
EUROPE
APAC
CANADA
  • US
    • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Home
  • Contributors
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • Magazine
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

  • Home
  • News

Recommended picks

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Advantages of Using Monoclonal Antibodies

Advantages of Using Monoclonal...

A Brief Overview Of Green Biotechnology Tools And Applications

A Brief Overview Of Green...

Key Advantages of Agtech in Farming

Key Advantages of Agtech in Farming

Nanotechnologys Impact on Environment: What to Know

Nanotechnologys Impact on...

How Automation in Pharmaceutical is Giving a New Direction to Drug Development

How Automation in Pharmaceutical is...

Ways Health Economics and Outcomes Research can Improve Decision Making Process

Ways Health Economics and Outcomes...

Top Agtech Industry Trends to Keep an Eye on

Top Agtech Industry Trends to Keep an...

Strategies to Mitigate Life Sciences Supply Chain Challenges

Strategies to Mitigate Life Sciences...

Brain's Immune Cells Can Guide the Treatment of Neurodegenerative Diseases

Life Sciences Review | Tuesday, October 27, 2020
Tweet

Human behavior depends on the excitation and inhibition of neurons, and scientists believe that they are responsible for keeping the circuit of activity in balance.


FREMONT, CA: According to research, it was discovered that immune cells are the brain and play a vital role in regulating behavior. As human behavior depends on the excitation and inhibition of the neurons, and scientists have always believed that neurons are largely responsible for keeping this circuit of activity in balance.


These immune cells, called microglia, are the scavengers that remove the dying cells. In a new study, the team displayed that, similar to inhibitory neurons, and microglia can also sense and suppress excessive neuronal activation. The researchers argued that the findings might have implications for treating the behavioral problems associated with neurodegenerative diseases.


The researchers lowered the population of microglia in mice by utilizing drugs to inhibit the protein receptor CSF1R. Doing so made the animals supersensitive to neuro stimulants. When they gave neuro stimulants to the altered mice, 90 percent of the animals developed long-lasting epileptic seizures, indicative of overexcited neurons. Only 11 percent of the control animals experienced seizures.


The researchers then identified the process behind neuron-microglia communication. When neurons are activated, they release ATP that provides energy for many activities in living cells. Microglia can detect and respond to ATP released from the synaptic junctions between neurons.


The researchers found microglia broke down ATP into adenosine (ADO), which then acts on specific receptors on active neurons' surface to suppress their activation. Blocking enzymes CD39 or CD73—which are involved in converting ATP into ADO—lowered ADO levels and rendered mice more susceptible to seizures due to neuro stimulants, the team reported.


The garbage-consuming role of microglia has already made them a popular target for researchers studying the neurodegenerative disease. A startup recently came to life with $30 million to develop new drugs for neurodegenerative diseases that target microglia dysfunction based on its role in nerve cell inflammation. They already have some animal data in amyotrophic lateral sclerosis, frontotemporal dementia, and age-related neuropathologies.


See Also: Top Immunotherapy Companies


Weekly Brief

loading
Towards a New World Order
> <
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue
  • Regulatory Services 2023

    Top Vendors

    Current Issue
  • Clinical Lab Equipment 2023

    Top Vendors

    Current Issue

Read Also

The Role of AI in Accurate Medical Writing

Patrik Renblad to Join Cantargia as Chief Financial Officer

Overview of the Life Sciences BPO Market

Dr. Zamaneh Mikhak Joins TFF Pharmaceutical as the New Chief Medical Officer

The Significance of AI in Medical Writing

The Importance of Technology in Multinational Clinical Research

Hepion Pharmaceuticals to Get a Total of $ 3.2 Million in Non-Dilutive Financing

Benefits that Medical Writing Offers

Loading...

Copyright © 2023 Life Sciences Review . All rights reserved. |  Subscribe |  About Us follow on linkedin

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://www.lifesciencesreview.com/news/brain-s-immune-cells-can-guide-the-treatment-of-neurodegenerative-diseases-nwid-151.html